These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3145291

  • 1. Valproate in the treatment of rapid-cycling bipolar disorder.
    McElroy SL, Keck PE, Pope HG, Hudson JI.
    J Clin Psychopharmacol; 1988 Aug; 8(4):275-9. PubMed ID: 3145291
    [Abstract] [Full Text] [Related]

  • 2. Rapid cycling bipolar disorder and its treatment with valproate.
    Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ.
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S57-61. PubMed ID: 8500080
    [Abstract] [Full Text] [Related]

  • 3. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 Apr; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

  • 4. A medication algorithm for treatment of bipolar rapid cycling?
    Calabrese JR, Woyshville MJ.
    J Clin Psychiatry; 1995 Apr; 56 Suppl 3():11-8. PubMed ID: 7883737
    [Abstract] [Full Text] [Related]

  • 5. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM.
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [Abstract] [Full Text] [Related]

  • 6. Phenomenology of rapid cycling manic depression and its treatment with valproate.
    Calabrese JR, Delucchi GA.
    J Clin Psychiatry; 1989 Mar; 50 Suppl():30-4. PubMed ID: 2494157
    [Abstract] [Full Text] [Related]

  • 7. Predictors of valproate response in bipolar rapid cycling.
    Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ.
    J Clin Psychopharmacol; 1993 Aug; 13(4):280-3. PubMed ID: 8376616
    [Abstract] [Full Text] [Related]

  • 8. Emerging perspectives on valproate in affective disorders.
    Post RM.
    J Clin Psychiatry; 1989 Mar; 50 Suppl():3-9. PubMed ID: 2494156
    [Abstract] [Full Text] [Related]

  • 9. Treatment guidelines for valproate in bipolar and schizoaffective disorders.
    McElroy SL, Keck PE.
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S62-6. PubMed ID: 8500081
    [Abstract] [Full Text] [Related]

  • 10. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
    Tohen M, Castillo J, Pope HG, Herbstein J.
    J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
    [Abstract] [Full Text] [Related]

  • 11. Valproate in bipolar disorder: the Canadian perspective.
    Joffe RT.
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
    [Abstract] [Full Text] [Related]

  • 12. Alternatives to lithium in the treatment of bipolar disorder.
    Keltner NL, Folks DG.
    Perspect Psychiatr Care; 1991 Apr; 27(2):36-7. PubMed ID: 1788043
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.
    Dilsaver SC, Swann AC, Shoaib AM, Bowers TC.
    J Psychiatry Neurosci; 1993 Mar; 18(2):61-6. PubMed ID: 8461283
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [Abstract] [Full Text] [Related]

  • 18. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE, McElroy SL.
    J Clin Psychiatry; 2002 Oct; 63 Suppl 10():13-7. PubMed ID: 12392348
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [Abstract] [Full Text] [Related]

  • 20. Health-economic implications of the onset of action of antimanic agents.
    Keck PE, McElroy SL, Bennett JA.
    J Clin Psychiatry; 1996 Jan; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.